Related Experiment Video

Updated: Nov 1, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.5K

Clarifying Progress on the Genomic Landscape of Actinic Keratosis

Matthew Hedberg1, John T Seykora1

  • 1Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

The Journal of Investigative Dermatology
|June 25, 2021
PubMed

Insights

Researchers identified key genetic mutations in actinic keratoses (AKs), a precancerous skin lesion. These genetic drivers are linked to risk factors like UV radiation and may explain the progression to cutaneous squamous cell carcinoma (cSCC).

Area of Science:

  • Dermatology
  • Oncology
  • Genetics

Background:

  • Cutaneous squamous cell carcinoma (cSCC) often develops from premalignant actinic keratoses (AKs).
  • Targeting AKs offers a therapeutic window to prevent cSCC development.
  • Understanding the genetic landscape of AKs is crucial for identifying progression drivers.

Purpose of the Study:

  • To characterize the genetic alterations present in actinic keratoses.
  • To identify specific gene mutations associated with risk factors like UV radiation (UVR) and azathioprine.
  • To elucidate signaling pathways involved in the transition from AK to cSCC.

Main Methods:

  • Comprehensive genetic profiling of actinic keratoses.
  • Analysis of mutation data in relation to known risk factors.
  • Identification of significantly mutated genes and associated pathways.

Main Results:

  • Discovery of significantly mutated driver genes in AKs.
  • Association of specific mutations with UVR exposure and azathioprine use.
  • Identification of key signaling pathways implicated in AK to cSCC progression.

Conclusions:

  • Actinic keratoses harbor distinct genetic alterations that drive progression.
  • Genetic drivers are influenced by environmental and therapeutic risk factors.
  • Targeting identified pathways may offer novel strategies for cSCC prevention.

More Related Videos

Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration10:09

Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration

Published on: February 28, 2013

13.9K
Cell Population Analyses During Skin Carcinogenesis06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

12.7K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K